Lonc-term safety of TNF-blockers

被引：0
|
作者：
Van Vollenhoven, R. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2008年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：720 / 720
页数：1
相关论文
共 50 条
  • [31] Rheumatoid arthritis: Eligibility criteria for TNF-blockers therapy in the hospital setting; A multivariate analysis. (The precept study)
    Meyer, O
    Sany, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 465 - 465
  • [32] No Clinically Relevant Changes in Coagulation Activation Between Patients Initiating TNF-blockers versus JAK-inhibitors
    Hansildaar, Romy
    Raadsen, Reinder
    Heslinga, Maaike
    Nurmohamed, Michael
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 812 - 814
  • [33] CHANGE OF ASDAS OVER 3 MONTHS IS A GOOD PREDICTIVE FACTOR FOR IMPROVEMENT OF METROLOGY INDEX AFTER LONG-TERM TREATMENT WITH TNF-BLOCKERS IN ANKYLOSING SPONDYLITIS
    Nam, E. J.
    Kwon, S. H.
    Eun, J. S.
    Kim, N. R.
    Kang, Y. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 758 - 758
  • [34] Leflunomide in combination with TNF-blockers for Methotrexate intolerance [Leflunomid als Kombinationspartner von TNF-Blockern bei Methotrexat-Unverträglichkeit]
    Krüger K.
    Manger B.
    Zeitschrift für Rheumatologie, 2009, 68 (2) : 165 - 168
  • [35] The impact of therapy with TNF-blockers on health-related quality of life in rheumatoid arthritis patients. A pilot study
    Abalos Medina, Gracia Maria
    Ruiz Villaverde, Gonzalo
    Sanchez Cano, Daniel
    Ruiz Villaverde, Ricardo
    Ramirez Rodrigo, Jesus
    Raya Alvarez, Enrique
    Villaverde Gutierrez, Carmen
    REUMATOLOGIA CLINICA, 2011, 7 (03): : 167 - 171
  • [36] FDA mandates enhanced safety check on TNF blockers
    不详
    FORMULARY, 2011, 46 (12) : 546 - 546
  • [37] CORRELATION BETWEEN TNF-BLOCKERS BIOAVAILABILITY AND FCGRIIA H131R POLYMORPHISM IN TUNISIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mahmoud, Ines
    Moalla, Myriam
    Sfar, Imen
    Saidane, Olfa
    Ben Tekaya, Aicha
    Tekaya, Rawdha
    Hamdi, Wafa
    Aouini, Saloua
    Kchir, Mohamed Montacer
    Gorgi, Yousr
    Abdelmoula, Leila
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1656 - 1656
  • [38] Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy
    Freund, Romain
    Granger, Benjamin
    Francois, Cecile
    Carcelain, Guislaine
    Ravaud, Philippe
    Mariette, Xavier
    Fautrel, Bruno
    PRESSE MEDICALE, 2018, 47 (02): : E9 - E13
  • [39] THE RESPONSE TO TNF-BLOCKERS TREATMENT OF SpA PATIENTS IS INFLUENCED BY THE INTERPLAY BETWEEN HLA-B27 AND GUT MICROBIOTA COMPOSITION AT BASELINE
    Vallier, M.
    Dougados, M.
    Ferreira, S.
    Menegatti, S.
    Bianchi, E.
    Rogge, L.
    Chamaillard, M.
    Miceli-Richard, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 752 - 752
  • [40] The Response to TNF-Blockers Treatment of Spa Patients Is Influenced By the Interplay between HLA-B27 and Gut Microbiota Composition at Baseline
    Vallier, Marie
    Dougados, Maxime
    Ferreira, Stephanie
    Menegatti, Silvia
    Bianchi, Elisabetta
    Rogge, Lars
    Chamaillard, Mathias
    Miceli-Richard, Corinne
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345